SP
Symmetry Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-779
| Closed | -$819K | – | 415 |
|
|
2024
Q2 | $819K | Hold |
779
| – | – | 0.04% | 200 |
|
|
2024
Q1 | $750K | Sell |
779
-94
| -11% | -$90.5K | 0.06% | 225 |
|
|
2023
Q4 | $770K | Sell |
873
-310
| -26% | -$273K | 0.04% | 207 |
|
|
2023
Q3 | $974K | Sell |
1,183
-163
| -12% | -$134K | 0.05% | 185 |
|
|
2023
Q2 | $967K | Sell |
1,346
-403
| -23% | -$290K | 0.05% | 195 |
|
|
2023
Q1 | $1.44M | Buy |
1,749
+164
| +10% | +$135K | 0.08% | 136 |
|
|
2022
Q4 | $1.14M | Sell |
1,585
-79
| -5% | -$57K | 0.07% | 161 |
|
|
2022
Q3 | $1.15M | Buy |
1,664
+134
| +9% | +$92.3K | 0.08% | 148 |
|
|
2022
Q2 | $904K | Sell |
1,530
-1,002
| -40% | -$592K | 0.06% | 189 |
|
|
2022
Q1 | $1.77M | Buy |
2,532
+1,637
| +183% | +$1.14M | 0.11% | 103 |
|
|
2021
Q4 | $565K | Hold |
895
| – | – | 0.04% | 354 |
|
|
2021
Q3 | $493K | Buy |
895
+80
| +10% | +$44.1K | 0.03% | 411 |
|
|
2021
Q2 | $455K | Buy |
815
+222
| +37% | +$124K | 0.03% | 461 |
|
|
2021
Q1 | $281K | Sell |
593
-539
| -48% | -$255K | 0.02% | 572 |
|
|
2020
Q4 | $547K | Sell |
1,132
-912
| -45% | -$441K | 0.04% | 347 |
|
|
2020
Q3 | $1.14M | Buy |
2,044
+898
| +78% | +$503K | 0.1% | 137 |
|
|
2020
Q2 | $715K | Buy |
+1,146
| New | +$715K | 0.09% | 95 |
|